Fiasp® is indicated to improve glycemic control in adults and children with diabetes.1
Instruct patients on basal-bolus treatment who forget a mealtime dose to monitor their blood glucose level to decide if an insulin dose is needed, and to resume their usual dosing schedule at the next meal.
No more waiting to eat
Rapid onset of appearance
Is Fiasp® covered?
Fiasp® is the same co-pay as NovoLog® (insulin aspart injection) 100 U/mL for covered patients; Coverage is similar